Oncogenic pathway of sporadic colorectal cancer with novel germline missense mutations in the hMSH2 gene

  • Authors:
    • Kanae Yamada
    • Xiaoling Zhong
    • Shinsaku Kanazawa
    • Junichi Koike
    • Kazunori Tsujita
    • Hiromichi Hemmi
  • View Affiliations

  • Published online on: July 1, 2003     https://doi.org/10.3892/or.10.4.859
  • Pages: 859-866
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The deficiency of the DNA mismatch repair (MMR) system is involved in tumorigenesis of either familial or sporadic colorectal cancers showing microsatellite instability (MSI). To investigate the involvement of the mutated hMSH2 gene in carcinogenesis, we searched for alteration of the gene in 15 MSI tumors of Japanese patients with sporadic colorectal cancer by a polymerase chain reaction (PCR)-single strand conformation polymorphism (SSCP) and DNA sequencing analyses. We found 20 alterations including 7 novel mutations, 6 germline and one somatic. To assume an oncogenic pathway of tumor of two patients carrying germline missense mutations, G40S located in an evolutionarily conserved amino-terminal motif and Y619C in a domain interacting with either hMSH3 or hMSH6, somatic mutations in 9 target genes of the MMR defect and in the p53 and K-ras genes and loss of heterozygosity (LOH) at the hMLH1 and p53 gene loci were then studied. In the tumor carrying G40S, other somatic hMSH2 mutations, G203R and 687delA in the (A)7 repeat, and 5 one-bp deletions in the target genes were found, while no mutation in the p53 and K-ras genes. These results indicate that G40S may affect the hMSH2 function and the tumor may be developed by a typical MSI pathway. In another tumor with Y619C, LOH at the hMLH1 gene locus, no mutation in MMR target genes, and two-hit inactivation of the p53 gene were detected. This MSI tumor seems to be developed by another than MSI pathway. These results indicate that there are different oncogenic pathways in the MSI sporadic colorectal cancers with germline missense mutations in the hMSH2 gene. We conclude that familial colorectal cancer-suspected cases exist in a small population of sporadic colorectal cancers.

Related Articles

Journal Cover

July-August 2003
Volume 10 Issue 4

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Yamada K, Zhong X, Kanazawa S, Koike J, Tsujita K and Hemmi H: Oncogenic pathway of sporadic colorectal cancer with novel germline missense mutations in the hMSH2 gene. Oncol Rep 10: 859-866, 2003.
APA
Yamada, K., Zhong, X., Kanazawa, S., Koike, J., Tsujita, K., & Hemmi, H. (2003). Oncogenic pathway of sporadic colorectal cancer with novel germline missense mutations in the hMSH2 gene. Oncology Reports, 10, 859-866. https://doi.org/10.3892/or.10.4.859
MLA
Yamada, K., Zhong, X., Kanazawa, S., Koike, J., Tsujita, K., Hemmi, H."Oncogenic pathway of sporadic colorectal cancer with novel germline missense mutations in the hMSH2 gene". Oncology Reports 10.4 (2003): 859-866.
Chicago
Yamada, K., Zhong, X., Kanazawa, S., Koike, J., Tsujita, K., Hemmi, H."Oncogenic pathway of sporadic colorectal cancer with novel germline missense mutations in the hMSH2 gene". Oncology Reports 10, no. 4 (2003): 859-866. https://doi.org/10.3892/or.10.4.859